Skip to content

Angiographic Contrast Management System, Model Part a and Part B

by Invasatec

510(k) K984231

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

4 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK984231 Date31 May 2000ClearedStatusActive

Recalls

4 recalls · FDA

    • Terminated Z-0744-2016 FDA Class II initiated 21 Dec 2015

    Reports related to ingress of air into the manifold.

    • Terminated Z-0359-2008 FDA Unclassified (pre-2012) initiated 3 Oct 2007

    Syringe Fracture: the syringe may be fractured, causing contrast to be sprayed from syringe fracture.

    • Terminated Z-1002-04 FDA Unclassified (pre-2012) initiated 19 May 2004

    Some of the sterile product packages were inadequately sealed prior to sterilization and as a result the package contents may not be sterile.

    • Terminated Z-0064-04 FDA Unclassified (pre-2012) initiated 2 Oct 2003

    Some of the automated manifold's 2.5 inch high-pressure lines for radiopaque contrast media, used in angiographic procedures, have separated where they are bonded to the manifold body of the device allowing contrast media to leak.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXT
Device Class
Class II
Regulation
21 CFR Part 870.1650
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Other devices from Invasatec